Share Name Share Symbol Market Type Share ISIN Share Description
Batm Advanced Communications Ld LSE:BVC London Ordinary Share IL0010849045 ORD ILS0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -3.80 -4.22% 86.20 443,716 16:35:14
Bid Price Offer Price High Price Low Price Open Price
85.00 86.00 91.00 85.00 91.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Technology Hardware & Equipment 93.75 0.95 0.07 1,275.2 382
Last Trade Time Trade Type Trade Size Trade Price Currency
17:27:03 O 891 86.20 GBX

Batm Advanced Communicat... (BVC) Latest News

More Batm Advanced Communicat... News
Batm Advanced Communicat... Investors    Batm Advanced Communicat... Takeover Rumours

Batm Advanced Communicat... (BVC) Discussions and Chat

Batm Advanced Communicat... Forums and Chat

Date Time Title Posts
27/11/202022:29Batm Advanced - A New Beginning17,832
12/6/202016:27BVC over-ramped and over-valued!120
15/4/202009:44BATM - Broadband bright future22,489
03/2/202008:05Coronavirus Investment - BATM2

Add a New Thread

Batm Advanced Communicat... (BVC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Batm Advanced Communicat... trades in real-time

Batm Advanced Communicat... (BVC) Top Chat Posts

Batm Advanced Communicat... Daily Update: Batm Advanced Communications Ld is listed in the Technology Hardware & Equipment sector of the London Stock Exchange with ticker BVC. The last closing price for Batm Advanced Communicat... was 90p.
Batm Advanced Communications Ld has a 4 week average price of 84p and a 12 week average price of 84p.
The 1 year high share price is 150.50p while the 1 year low share price is currently 30p.
There are currently 443,543,901 shares in issue and the average daily traded volume is 669,002 shares. The market capitalisation of Batm Advanced Communications Ld is £382,334,842.66.
owenski: "owenski - 29 Sep 2020 - 07:56:47 - 17618 of 17783 Odd share price action here considering the supposed good news flow. Looks like it's setting up to go of a cliff." As said before, the share price has looked weak here for some time, maybe it got a bit overvalued??
car1pet: I suspect the rise to 150p was driven by a belief that the medical side would grow significantly but maybe now the vaccine is becoming available the price is adjusting to a more normal world in the future. Remember share prices are about the future not the here and now. Alll IMO DYOR
paulisi: Understood.Novacyt share price down 40% and there revenue is nearly all covid related...
picsous: Leewain, apologies - can't keep up with the share price. The rise to 150 was even more surprising, Covid wabbles? I guess we are in more conservative waters now for a while so will wait and see if get to 90p.
picsous: Buy more BATM? Isn't £1 a resistance level now? I am counting on seeing the share price go below 90p.
fse: This is now on Investors Chronicle Site for those who did not get the earlier scoop. Looks like he is referring to NFVTime. I have had a chance to read it over and would agree with his synopsis. .... heres the update "Investors have failed to grasp the significance of the latest contract wins from BATM Advanced Communications (BVC:115.5p), a provider of medical laboratory systems, diagnostic kits, cyber security and network solutions. The Israel-based technology group is now gaining significant traction in commercialising its valuable intellectual property, as I noted after BATM signed up its first tier 1 telecoms customer for its NFVTime virtual networking solution (‘Bull market pointers’, 1 September 2020). Operating on both Arm-based and Intel-based architectures, the cutting-edge technology enables network carriers to remotely deploy their own virtualised software-based networks. Analysts at house broker Shore Capital believe that revenue from this one customer alone could scale into a multi-million dollar recurring base over the next five years. NFV is critical in leveraging the benefits offered by 5G and the Internet of Things, so expect many more tier one customers to adopt the technology in due course. BATM’s medical laboratory systems business is firing on all cylinders, too, having just received an initial €4.3m (£3.9m) order for its Covid-19 Real-Time PCR diagnostic antigen test kits and instruments from a major global private laboratory group. BATM expects to receive “further significant orders from this customer during the current quarter and over the next 12 months”. In addition, the directors have updated investors on the progress being made on a raft of new diagnostic kits. BATM’s new multi-pathogen respiratory molecular diagnostics kit is in the final validation phase, with production and deliveries expected to commence shortly. In less than an hour the test can identify and differentiate between respiratory viruses including those that cause Covid-19, flu and the common cold. As the flu season approaches, this could be a game changer for medical authorities around the world. BATM is also commencing production of its new at-home test kit for flu, developed in partnership with Novamed, after being CE certified and validated. Finally, BATM has started to deliver its Covid-19 antigen kit, which has been upgraded to detect the spike (S) protein, thus providing more accurate results by identifying the virus even in those with a low viral load. This is important in preventing non- and pre-symptomatic individuals from unknowingly spreading the infection. It’s my strong view that revenues and profits from BATM’s high-growth segments will ramp up sharply in the coming years and in the process dramatically reduce BATM’s enterprise valuation to cash profit multiple of 42 times (based on 2020 estimates). The positive growth trends at work here also justify maintaining my buy recommendation even though the shares have already delivered a 540 per cent gain since I included them in my 2017 Bargain Shares portfolio. A return to this year’s 150p share price highs, and beyond, is not unrealistic. Buy.
wizzkid211: BATM Advanced Communications Ld Major new customer for COVID-19 diagnostic tests October 05 2020 - 02:00AM UK Regulatory (RNS & others) Alert Print Share On Facebook TIDMBVC RNS Number : 0233B BATM Advanced Communications Ld 05 October 2020 LEI: 213800FLQUB9J289RU66 5 October 2020 BATM Advanced Communications Limited ("BATM" or "the Group") BATM receives initial EUR4.3m order from major lab for COVID-19 diagnostic tests New significant customer order for Real-Time PCR test kits and instruments to be delivered this year BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is delighted to announce that it has received an initial EUR4.3m order for its COVID-19 Real-Time PCR diagnostic test kits and instruments. The order is from a major new customer and is to be delivered during Q4. The Group also provides an update on its new diagnostic tests being developed for respiratory diseases. The new customer is a significant global private laboratory group headquartered in Italy that provides COVID-19 testing throughout Europe, primarily for large businesses such as airports. The order is for the Group's Real-Time PCR (antigen) test that diagnoses whether an individual is currently infected with SARS-CoV-2, the virus that causes the disease Coronavirus 2019 (COVID-19). The customer has also purchased, as part of the same order, the Group's Ampilab qPCR and Extralab extractor instruments. BATM expects to receive further significant orders from this customer during Q4 and over the next 12 months. The Group's Ampilab 6 band qPCR instrument can run all standard test kits, but also advanced 5 (4+1) gene kits, such as the Group's newest COVID-19 antigen kit, with great speed and accuracy. As a result, it is a very cost efficient solution for labs. In addition, the Group is pleased to provide the following progress updates on its new testing kits: -- The Group has started to deliver its COVID-19 antigen kit that was upgraded to detect the spike (S) protein, as announced on 15 July 2020. By being able to detect the S gene, this test can provide more accurate results by identifying the virus even in those with a low viral load, which is important in preventing non- and pre-symptomatic individuals from unknowingly spreading the infection. -- The new multi pathogen respiratory kit, also announced on 15 July 2020, is in the final validation phase and production and deliveries are expected to commence during Q4. -- Production is commencing of the Group's jointly-developed home test kit for flu after being CE certified and validated. -- The Group is making strong progress with the jointly-developed COVID-19 home test kit, which is at an advanced development stage. Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are pleased to have received this order from a new significant customer for our COVID-19 test kits and diagnostic instruments. The substantial interest in these solutions is growing as the pandemic prevails throughout much of the world and we head towards flu season. We believe that we will receive further sizeable orders from our existing customers as well as continue to gain new customers for these products. "We are also delighted with the progress that we have made with our newly-developed tests for COVID-19, flu and other respiratory disease. Thanks to our innovative diagnostic platform, we can offer a high-quality comprehensive solution to help protect public health in the current pandemic and beyond." Enquiries:
deltaham: Here's the impressive article: Profiting from 5G BATM Advanced Communications (BVC:135p), a provider of medical laboratory systems, diagnostic kits, cyber security and network solutions, has made an incredibly important announcement since I covered the interim results (‘In search of value opportunities’, 17 August 2020). It’s one that has prompted me to upgrade my run profits stance on the shares to an outright buy recommendation. That’s because the company has signed up its first tier 1 customer for the group’s NFVTime virtual networking solution. The cutting-edge technology enables network carriers to remotely deploy their own virtualised software-based networks and operates on both Arm-based and Intel-based architectures. The customer is a leading Asian telecommunications provider that serves enterprise and wholesale customers in more than 160 countries and 3,000 cities across the Americas, Asia, Europe, Middle East and Africa. It has licenced BATM’s NFVTime operating system for a minimum of three years. Analysts at house broker Shore Capital estimate that the market for virtualisation services “stretches into tens of billions of dollars” and revenue from the new tier 1 customer has “potential to scale into a multi-million dollar, recurring base over the next five years.” It’s incredibly high margin, too, with gross margin “building up from the 80 per cent range”. That’s a significantly higher margin than BATM makes on its traditional carrier Ethernet products. Moreover, expect further contract wins to be announced as other large tier 1 customers adopt the technology, given that NFV is a critical element in leveraging the benefits offered by 5G and Internet of Things. This highlights the potential for BATM’s revenue and cash flow to scale up rapidly. Not surprisingly, investors have reacted positively to the news. BATM’s share price rallied 15 per cent following the contract win taking the total return on the holding to 650 per cent since I included the shares in my 2017 Bargain Shares portfolio. I now feel that the earnings upgrade cycle I previously highlighted is poised to accelerate. I also feel that BATM is a US$1bn market capitalisation company in the making, implying a new target price of 171p. A cash profit multiple of 50 times to enterprise valuation may not seem a bargain, but given the high margin nature of BATM’s revenue streams, and the way it is monetising its patent protected IP, that multiple could drop like a stone if further NFV contracts are secured. From a technical perspective, a chart break-out above the 19-year high of 150p would confirm the next up-leg in the share price is underway. On a bid-offer spread of 134.5p to 135p, I rate BATM’s shares a buy.
reeltime: This positive news should give us a boost today........ BATM Advanced Communications Ld Successful proof-of-concept with Vodafone 05/08/2020 8:09am UK Regulatory (RNS & others) Batm Advanced Communicat... (LSE:BVC) Intraday Stock Chart Wednesday 5 August 2020 Click Here for more Batm Advanced Communicat... Charts. TIDMBVC RNS Number : 1987V BATM Advanced Communications Ld 05 August 2020 LEI: 213800FLQUB9J289RU66 5 August 2020 BATM Advanced Communications Limited ("BATM" or "the Group") BATM and Arm successfully complete proof-of-concept with Vodafone Arm-based uCPE, which includes Group's NFVTime solution, successfully tested by Vodafone in the UK BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces the successful completion of a proof-of-concept by leading network operator, Vodafone, of the Arm-based uCPE that is run on the NFVTime operating system developed by the Group's wholly-owned subsidiary, Telco Systems. As noted by Arm in its announcement of 4 August 2020, highlights from the proof-of-concept include: -- This joint solution can 'effectively scale down the cost of deploying services [for network operators] while increasing system performance to levels not seen by other platforms' -- Telco Systems' NFVTime 'complements the hardware efficiency by enabling a tightly integrated virtualization platform' -- Gavin Young, Head of Fixed Access Center of Excellence at Vodafone, 'made it clear that this project is a major milestone toward a new way of deploying digital services' The Arm-based uCPE was tested by Vodafone Group labs in the UK for both small/medium business and enterprise use-cases. The solution performed successfully in the deployment and management of virtual network functions and was able to handle high traffic requirements. This solution enables network operators to benefit from a high-performing network with lower energy consumption, operating costs and emissions. Telco Systems continues to work closely with Arm and Vodafone as they prepare for the next step in the process. The Group's NFVTime operating system is integrated with Arm technology to be used on Arm-based uCPE related SoCs (system-on-a-chip). This solution, jointly developed by BATM and Arm, enables network carriers to deploy their own virtualised networks, which can also be a key element in allowing them to leverage the benefits offered by 5G. Dr Zvi Marom, Chief Executive Officer of BATM, said: "We are delighted with the successful outcome of this proof-of-concept under our strategic agreement with Arm. Our NFV ecosystem is designed to support high traffic, which is an absolute must in the implementation of business connectivity and 5G technologies and running applications such as those to enable the Internet of Things. Also, there has been a notable increase in data consumption since the COVID-19 outbreak and, as we all get used to new ways of working and keeping in touch with each other, we believe that better and more sophisticated mobile-based applications are needed more than ever to facilitate this new norm. "Our congratulations to Arm, Vodafone and the Telco Systems teams on completing the proof-of-concept despite all the restrictions imposed by the pandemic. We look forward to reporting progress with this project as well as the other proof-of-concepts taking place currently. " hTTp://
steeplejack: The company is involved in all the areas that currently transfix the market....5G enhanced communication solutions,defence,cyber security,diagnostic kits and ventilators.The company has a full LSE listing.It has experienced management and good political connections.It is cash generative.Meanwhile the historic PE is around 120x.That's somewhat daunting but since profits could well triple,if not quadruple in due course,the prospective multiple is possibly in the 30s.If you look at the chart,BVC was around the 50p mark a year ago.Things were meaningfully improving before COVID emerged.Its not as if the share price rise has been exponential like Novacyt.All in all,I'm pretty relaxed about holding despite recent share price gains.
Batm Advanced Communicat... share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Batm Advan..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201129 05:01:47